Navigation Links
Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
Date:10/16/2007

dialysis and/or pre-dialysis patients. There are also risks and uncertainties described in reports filed by Genzyme with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, including without limitation the information under the heading "Risk Factors" in the Management's Discussion and Analysis of Financial Condition and Results of Operations section of the Genzyme Quarterly Report on Form 10-Q for the quarter ending June 30, 2007. Genzyme cautions investors not to place substantial reliance on the forward-looking statements contained in this press release. These statements speak only as of the date of this press release, and Genzyme undertakes no obligation to update or revise the statements.

Genzyme(R) and Renagel(R) are registered trademarks and Renvela(TM) is a trademark of Genzyme Corporation. All rights reserved.

Genzyme's press releases and other company information are available at http://www.genzyme.com and by calling Genzyme's investor information line at 1-800-905-4369 within the United States or 1-678-999-4572 outside the United States.

Media Contact: Investor Contact:

Erin Emlock Patrick Flanigan

(617) 768-6923 (617) 768-6563


'/>"/>
SOURCE Genzyme
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Genzyme Announces First Phase III Study of Tolevamer in Diarrhea Patients
2. Fresh warnings to doctors regarding abortion pill
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Will anxiety regarding fertility treatment affect the chances of conception?
5. Changing Trends Regarding Insurance Cover For Weight Reduction Surgery
6. Indian Government warns Gujarat regarding possibility of bird flu
7. Leeches Provide Clues Regarding The Prevention Of Heart Disease
8. AIDS control requires co-coordinated move regarding safe sexual practices
9. Legal Action against Authority Regarding Outbreak of Legionnaires’ Diseas
10. Mixed Opinion Regarding Common Medical And Engineering Entrance Test
11. Adolescents Influenced By Maternal Attitude Regarding Weight Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...g the reaction of blood vessels in the eyes may of...w blood vessels in // the brain react to high blo...w study finds the drug candesartan cilexetil, also...in the eye, which can be slowed from the result of...
...estrogen alone will not prevent chronic diseases i.... However it is found to increase // the risk of s...ding to the latest research. For the study investi...ne estrogen alone or in combination with progestin...
... have a brother with prostate cancer are twice as ...udy shows// more men realize this fact and are tak...ompared data from two studies, researchers asked m...are currently taking vitamins or supplements to pr...
...ng waistline is bad for your health, but now a new...or your health.// When a company downsizes, it of...ly, the workers are concerned about their job and ...ngly shows when a company expands quickly, workers...
Other Medicine News:
(Date:8/21/2008)....J. and EMERYVILLE, Calif., Aug. 21 /PRNewswire-Fi... and Onyx Pharmaceuticals, Inc.,(Nasdaq: ONXX ) t...patients,in the STORM Sorafenib as Adjuvant Treatm...lar Carcinoma trial. The randomized, double-blind,...xavar(R) (sorafenib),tablets as adjuvant treatment...
(Date:8/20/2008)...Aug. 20 /PRNewswire-USNewswire/ -- Graduated compr... deep vein thrombosis (DVT) in,hospitalized patien... at,risk for potentially-deadly blood clots, accor...llas., Their findings appear in the September iss...patients are at increased risk for blood clots aft...
(Date:8/19/2008)...M, Pa., Aug. 19 /- Particle Sciences ...uting polymers) development and,pilot production c...,extrusion and injection molding line. The core o...mpounding extruder and Nissei 20T injection,molder...ed polymeric,devices. This addition gives Particle...
(Date:8/18/2008)...WN, Pa., Aug. 18 /PRNewswire-USNewswire/ -- Due to...nfected mosquitoes in,southeastern Pennsylvania, t...county partners will be stepping up efforts this w...- or are most likely to carry -- the virus., Whil...een confirmed,this year (a 27-year-old Montgomery ...
Breaking Medicine Technology:Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 2Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 3Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 4Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 5Dallas Researchers Find Compression Stockings Improperly Used 2Particle Sciences Expands Its Combination Product Capabilities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3ReBuilder Medical Technologies Inc Increases Manufacturing Space to Meet Demand 3954 1ReBuilder Medical Technologies Inc Increases Manufacturing Space to Meet Demand 3954 2ReBuilder Medical Technologies Inc Increases Manufacturing Space to Meet Demand 3954 3TopSpin Medical Appoints Cindy Setum Ph D Vice President Clinical Affairs 1321 1TopSpin Medical Appoints Cindy Setum Ph D Vice President Clinical Affairs 1321 2MultiVu Video Feed 3A Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With 22Silence the Sounds of Pertussis 22 3946 1MultiVu Video Feed 3A Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With 22Silence the Sounds of Pertussis 22 3946 2Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast Ovar 3941 1Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast Ovar 3941 2Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast Ovar 3941 3
...TSX: BMR, TORONTO, July 10, 2007 /PRNewswire-First...eutical company dedicated to the,development and c...ced that new research published by an independent ...n important molecular,target for the development o.... , The researchers identified that the loss of NO...
... ,Animal Study Confirms Caprospinol,s (SP-233) Ab...Cells to Recover Memory Function , In Vivo ,Proof ...een Removing Beta Amyloid Plaque and Memory Recove...Samaritan,Pharmaceuticals Inc. (AMEX:LIV), a devel...t has confirmed Caprospinol,s (SP-233),efficacy in...
Other Medicine Technology:Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 2Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 3Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 4Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease 2Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease 3
Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility
ManuTrain is an active wrist support that has optional features for increased stabilization.
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
3-Point® Polycentric Hinged Ulnar Deviation Splint uses safe, mild to moderate force to align the hand with ulnar deviation at the MP joints. Dorsal-based splint does not impede grasp or pinch. R
Medicine Products: